Literature DB >> 2705506

Walker carcinosarcoma cells damage endothelial cells by the generation of reactive oxygen species.

S G Shaughnessy1, M R Buchanan, S Turple, M Richardson, F W Orr.   

Abstract

The passage of circulating tumor cells across vessel walls is an important step in cancer metastasis and is promoted by endothelial injury. Because Walker carcinosarcoma 256 (W256) cells generate oxygen-derived free radicals after cellular activation, the authors tested the hypothesis that these cancer cells can damage endothelial monolayers by producing such reactive oxygen species. To confirm that oxygen-derived radicals can damage endothelial cells, 3H-2-deoxyglucose-labeled human endothelial cell monolayers were exposed to xanthine oxidase in the presence of 0.2 mmol/l xanthine. 3H-2-deoxyglucose release was observed after the addition of xanthine oxidase in concentrations ranging from 6.5 x 10(-3) to 52 x 10(-3) units/ml. The extent of damage correlated with xanthine oxidase-dependent chemiluminescence (r = 0.91). Chemiluminescence assays in the presence of 5 x 10(-5) M luminol confirmed activation of the W256 cells by 1 x 10(-6) M chemotactic peptide fMLP. When fMLP-activated activated W256 cells were incubated with endothelial monolayers, concentrations of 2 x 10(6) to 6 x 10(6) W256 cells/ml were found to cause a 27% increase in the specific release of 2-deoxyglucose after a 90-minute incubation. A small but significant increase in 3H-2-deoxyglucose release also was observed in the absence of fMLP. Detection of 3H-2-deoxyglucose release in the presence of activated or unactivated tumor cells was dependent on preincubating the endothelial cell monolayer with 1 mM buthionine sulfoximine, an inhibitor of glutathione synthesis. Under these conditions, the specific release of 3H-2-deoxyglucose was increased from nondetectable levels to 21%, in the presence of 6.5 x 10(-3) units of the oxidase. Cultured W256 cells promoted isotope release from endothelial cell monolayers when activated with phorbol myristate acetate. Catalase (1000 units/ml) inhibited the tumor cell-induced release of 3H-2-deoxyglucose by 84% whereas superoxide dismutase, even at concentrations of 1 mg/ml, had no effect. A requirement for cell contact was shown because addition of cell-free supernatants from fMLP activated tumor cells did not cause 3H-2-deoxyglucose release and because pretreatment of W256 cells with 1 microM cytochalasin B inhibited their ability to promote isotope release even while increasing tumor cell-generated chemiluminescence threefold. Electron microscopy revealed that fewer cytochalasin B-treated W256 cells were attached to the endothelial cell monolayer than in untreated controls. It is concluded that the W256 tumor cells can damage endothelial cells directly via a mechanism involving production of reactive oxygen species.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2705506      PMCID: PMC1879790     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  32 in total

1.  Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes. An in vitro model of immune vascular damage.

Authors:  T Sacks; C F Moldow; P R Craddock; T K Bowers; H S Jacob
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

Review 2.  Oxy-radicals and related species: their formation, lifetimes, and reactions.

Authors:  W A Pryor
Journal:  Annu Rev Physiol       Date:  1986       Impact factor: 19.318

3.  Superoxide production induced in rabbit polymorphonuclear leukocytes by synthetic chemotactic peptides and A23187.

Authors:  E L Becker; M Sigman; J M Oliver
Journal:  Am J Pathol       Date:  1979-04       Impact factor: 4.307

4.  Stimulation of endothelial cells by protease activity in commercial preparations of xanthine oxidase.

Authors:  A Ager; D J Wenham; J L Gordon
Journal:  Thromb Res       Date:  1984-07-01       Impact factor: 3.944

5.  Enhancement of pulmonary metastases by x-irradiation in rats bearing mammary cancer.

Authors:  T L Dao; H Yogo
Journal:  Cancer       Date:  1967-11       Impact factor: 6.860

6.  Rat neutrophil activation and effects of lipoxygenase and cyclooxygenase inhibitors.

Authors:  P A Ward; M C Sulavik; K J Johnson
Journal:  Am J Pathol       Date:  1984-08       Impact factor: 4.307

7.  In vitro detection of endothelial cell damage using 2-deoxy-D-3H-glucose: comparison with chromium 51, 3H-leucine, 3H-adenine, and lactate dehydrogenase.

Authors:  S P Andreoli; R L Baehner; J M Bergstein
Journal:  J Lab Clin Med       Date:  1985-09

8.  Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria.

Authors:  E A Jaffe; R L Nachman; C G Becker; C R Minick
Journal:  J Clin Invest       Date:  1973-11       Impact factor: 14.808

9.  Artificial metastases and decrease of fibrinolysis in the nude mouse lung after hemithoracic irradiation.

Authors:  H Hirata; K Tanaka
Journal:  Clin Exp Metastasis       Date:  1984 Oct-Dec       Impact factor: 5.150

10.  Chemiluminescence of phagocytic cells caused by N-formylmethionyl peptides.

Authors:  G E Hatch; D E Gardner; D B Menzel
Journal:  J Exp Med       Date:  1978-01-01       Impact factor: 14.307

View more
  11 in total

1.  As2O3 induces apoptosis in human hepatocellular carcinoma HepG2 cells through a ROS-mediated mitochondrial pathway and activation of caspases.

Authors:  Lin Jiang; Le Wang; Lei Chen; Guo-Hong Cai; Qin-You Ren; Jian-Zong Chen; Heng-Jun Shi; Yong-Hong Xie
Journal:  Int J Clin Exp Med       Date:  2015-02-15

2.  The role of nicotinamide adenine dinucleotide phosphate oxidase-derived reactive oxygen species in the acquisition of metastatic ability of tumor cells.

Authors:  Futoshi Okada; Masanobu Kobayashi; Hiroki Tanaka; Tokushige Kobayashi; Hiroshi Tazawa; Yoshihito Iuchi; Kunishige Onuma; Masuo Hosokawa; Mary C Dinauer; Nicholas H Hunt
Journal:  Am J Pathol       Date:  2006-07       Impact factor: 4.307

3.  Tumour-cell-endothelial interactions: free radicals are mediators of melanoma-induced endothelial cell damage.

Authors:  F A Offner; J Schiefer; H C Wirtz; I Bigalke; M Pavelka; G Hollweg; C Ensinger; B Klosterhalfen; C Mittermayer; C J Kirkpatrick
Journal:  Virchows Arch       Date:  1996-05       Impact factor: 4.064

4.  Enhancing effect of thoraco-laparotomy on liver metastasis and the role played by active oxygens in its mechanism.

Authors:  T Hirai; A Yoshimoto; T Iwata; Y Yamashita; M Kuwahara; T Toge
Journal:  Surg Today       Date:  1997       Impact factor: 2.549

5.  Inhibition of angiogenesis and tumor growth in the brain. Suppression of endothelial cell turnover by penicillamine and the depletion of copper, an angiogenic cofactor.

Authors:  S S Brem; D Zagzag; A M Tsanaclis; S Gately; M P Elkouby; S E Brien
Journal:  Am J Pathol       Date:  1990-11       Impact factor: 4.307

6.  The effect of reactive oxygen species on the biosynthesis of collagen and glycosaminoglycans in cultured human dermal fibroblasts.

Authors:  H Tanaka; T Okada; H Konishi; T Tsuji
Journal:  Arch Dermatol Res       Date:  1993       Impact factor: 3.017

Review 7.  Adhesion molecules and their role in cancer metastasis.

Authors:  R M Lafrenie; M R Buchanan; F W Orr
Journal:  Cell Biophys       Date:  1993 Aug-Dec

Review 8.  Cancer cell interactions with injured or activated endothelium.

Authors:  R Lafrenie; S G Shaughnessy; F W Orr
Journal:  Cancer Metastasis Rev       Date:  1992-11       Impact factor: 9.264

9.  Interaction of human malignant melanoma (ST-ML-12) tumor spheroids with endothelial cell monolayers. Damage to endothelium by oxygen-derived free radicals.

Authors:  F A Offner; H C Wirtz; J Schiefer; I Bigalke; B Klosterhalfen; F Bittinger; C Mittermayer; C J Kirkpatrick
Journal:  Am J Pathol       Date:  1992-09       Impact factor: 4.307

10.  Expression of Mn-Superoxide Dismutase Gene in Nontumorigenic and Tumorigenic Human Mammary Epithelial Cells.

Authors:  Sutapa Mukhopadhyay; Salil K Das; Shyamali Mukherjee
Journal:  J Biomed Biotechnol       Date:  2004
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.